Dendreon Corporation

The Burnham Institute

Serono Genetics Institute S.a.

Animal Cell Therapies, Inc.

Animal Cell Therapics, Inc.

Jiunn-chern Yeh

Edwin L Madison

Edgar Ong

Kathryn J Petrucci

Amanda Reilly

Minoru Fukuda

John Mark Lucas

Deno Dialynas

Edgar O Ong

Transport of containers for biologic products in secure thermal isolation may be facilitated by a containment apparatus. The containment apparatus may include a first component and a second component. The first component may comprise one or more sidewalls that may form an enclosed volume of the first component. The enclosed volume may be fluidly sealed from an environment surrounding the first component and at least partially filled with cooling media. The first component may comprise one or more recessed wells configured to receive at least part of individual containers. At least part of individual recessed wells may come into contact with cooling media within the enclosed volume to facilitate heat transfer between the cooling media and individual containers disposed in individual recessed wells.

Systems, methods, and apparatuses for securing cell-based products for transport in thermal isolation

Provided herein is are polypeptides that include the protease domain of a type II transmembrane serine protease (MTSP) as a single chain. Methods using the polypeptides to identify compounds that modulate the protease activity of an MTSP are provided. Also provided are MTSPs designated MTSP3 and MTSP4 and a form of an MTSP designated MTSP6.

Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon

The present invention relates to the field of obesity research. Obesity is a public health problem that is serious and widespread. A compound, homotrimer of OBG3 polypeptide fragment comprising globular domain and all or part of OBG3 collagen-like region, has been identified that has utility for reducing body mass, for maintaining weight loss, and for treating obesity-related diseases and disorders. These obesity-related diseases and disorders include hyperlipidemias, atherosclerosis, diabetes, and hypertension.

Homotrimeric extended OBG3 globular head and uses thereof

Provided herein are polypeptides designated CVSP14 polypeptides that exhibit protease activity as a single chain or as an activated two chain form. Methods using the polypeptides to identify compounds that modulate the protease activity thereof are provided. The polypeptides also serve as tumor markers.

Nucleic acid molecules encoding serine protease CVSP14, the encoded polypeptides and methods based thereon

Provided herein are type II transmembrane serine protease 10 (MTSP10) polypeptides. Zymogen and activated forms of these polypeptides as well as single and two chain forms of the protease domain are also provided. Methods using the polypeptides to identify compounds that modulate the activity of an MTSP10 are provided.

Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon

The present invention provides a substantially pure C2GnT-M polypeptide or a functional fragment or derivative thereof, wherein C2GnT-M is characterized as a polypeptide having core 2, core 4 and I branching .beta.-1.fwdarw.6-N-acetylglucosaminyltransferase activities. The invention also provides a substantially pure C2GnT-M peptide, wherein the peptide is immunogenic. Also provided is a method of modifying an acceptor molecule by contacting the acceptor molecule with a substantially pure C2GnT-M polypeptide or a functional fragment under conditions that allow addition of core 2, core 4 or I GlcNAc linkages to the acceptor molecule, and an acceptor molecule produced by the method. Also provided is a substantially pure nucleic acid molecule having substantially the nucleic acid sequence designated SEQ ID NO: 1, or the complement thereof. The invention also provides a substantially pure nucleic acid molecule encoding C2GnT-M or a functional fragment or derivative thereof, or the complement of the nucleic acid molecule, wherein C2GnT-M is characterized as a polypeptide having core 2, core 4 and I branching P-1.fwdarw.6-N-acetylglucosaminyltransferase activities. Also provided are vectors and host cells containing nucleic acid molecules encoding C2GnT-M or a functional fragment or derivative thereof. A substantially pure oligonucleotide having a nucleotide sequence corresponding to or complementary to at least 15 nucleotides from SEQ ID NO: 1, SEQ ID NO: 9 or SEQ ID NO: 13 is also provided. The invention further provides an antibody or antigen binding fragment thereof that is specifically reactive with C2GnT-M or with a functional fragment or derivative hereof. Methods of detecting the presence of C2GnT-M in sample are also provided.

Growing community of inventors

San Diego, CA, United States of America

Jiunn-chern Yeh